Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
about
The Role of miRNAs in the Regulation of Pancreatic Cancer Stem CellsDysregulation of microRNA biogenesis in cancer: the impact of mutant p53 on Drosha complex activitymiRNA biogenesis: biological impact in the development of cancerGetting TRAIL back on track for cancer therapyAberrant DR5 transport through disruption of lysosomal function suggests a novel mechanism for receptor activationCancer stem cells: involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics.MicroRNAs as emerging biomarkers and therapeutic targets for pancreatic cancerLet-7g reverses malignant phenotype of osteosarcoma cells by targeting Aurora-B.Gene expression profiling associated with angiotensin II type 2 receptor-induced apoptosis in human prostate cancer cellsTRAIL-R2 promotes skeletal metastasis in a breast cancer xenograft mouse model.Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancerLeveraging Cancer Therapeutics for the HIV Cure Agenda: Current Status and Future DirectionsPri-let-7a-1 rs10739971 polymorphism is associated with gastric cancer prognosis and might affect mature let-7a expression.Technological advances in precision medicine and drug development.Compartmentalization of TNF-related apoptosis-inducing ligand (TRAIL) death receptor functions: emerging role of nuclear TRAIL-R2.Ilf3 and NF90 functions in RNA biology.Journey of TRAIL from Bench to Bedside and its Potential Role in Immuno-Oncology.Stroma-regulated HMGA2 is an independent prognostic marker in PDAC and AAC.Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.Cancer and necroptosis: friend or foe?Targeting cell death signalling in cancer: minimising 'Collateral damage'.NF45 overexpression is associated with poor prognosis and enhanced cell proliferation of pancreatic ductal adenocarcinoma.Intracellular localization of DR5 and related regulatory pathways as a mechanism of resistance to TRAIL in cancer.HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.The role of the TNF receptors and apoptosis inducing ligands in tumor growth.Nanocarriers for TRAIL delivery: driving TRAIL back on track for cancer therapy.Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy.miR-541 suppresses proliferation and invasion of squamous cell lung carcinoma cell lines via directly targeting high-mobility group AT-hook 2.Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.TWEAK Negatively Regulates Human Dicer.Cytokeratin 8/18 protects breast cancer cell lines from TRAIL-induced apoptosis.LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
P2860
Q26752473-F9BE4B45-F6D1-4C4A-9985-2257E88432B3Q26766173-EA7D5E6A-181B-4959-903A-FD5492AB5601Q26824263-76EDC15E-1126-47F0-9273-3AB3D410CF4BQ27027460-430ACA66-0AEE-4D4A-8708-3B6F23F61FA3Q28817289-B6327AF9-BCD7-48C4-9DE4-30A5DA73EDE5Q34067873-E8FB0D57-3417-4501-8F19-56200DBB41CCQ34093798-441C3E4F-765F-411C-B0FB-5A202AE325DEQ34121288-CE6EF791-47F4-4395-A1E4-462474AD3889Q35127888-D9B3A874-CF21-4B15-8E24-0A273B11904AQ35832412-42C8A9E9-D1BC-482F-9E3C-7B9CF39692F5Q35881362-4D3B3370-F21E-4C23-BF2A-C4D829F0C997Q36030989-CC62A948-57E0-4D53-BEF8-9CDBB3C5A19DQ37078509-21C4C835-46B8-412C-8F1E-916D46D3713BQ37244501-9C287E96-7147-4EB2-8CAD-C5B0329DAD07Q38244150-27BE27D5-CF49-4F08-8247-86888AC4FE51Q38261272-20A89DE4-980A-4937-9256-9EE1759CAD48Q38557486-9BDDDE21-65E1-4CF7-B514-E182F85BC805Q38702943-5C3BB4FE-5F4B-4B3B-ABF3-2B35B2844825Q38703766-CBDD1D19-C1CF-47C0-8771-A81B429CBA48Q38799139-03385B2F-0864-49AD-9D43-9F4C860DFA5FQ38824157-3565C15D-2AE7-451B-BEEE-FB611E94440BQ38843622-76257F96-F0DD-4220-A704-7A7DF16B4894Q38924056-2487641B-7152-4A94-B51C-218B95228B39Q39017066-096CD0C6-FA15-4932-8118-8023E12C9EE6Q47672214-F2D6F4BB-2B31-4985-8085-F833B1E95429Q50070105-81F497D2-5E72-4770-8E4A-B23064A513D5Q51760860-10969C52-D8C7-40D4-ADB3-3502C87058F7Q52586325-63ED6753-C9B0-4C4C-9601-89C633FEBA0DQ53708408-0891AEDF-AB6E-4B0C-8D5B-599CCCF30403Q54503440-016AE574-B75A-4F81-87E9-38FEFA98C528Q55101408-FFA5B0A2-58B2-45DE-AFF1-C29B6F767448Q58788537-9DCE6EFA-040E-4A05-9820-DE0557AEA04A
P2860
Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@ast
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@en
type
label
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@ast
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@en
prefLabel
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@ast
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@en
P2093
P50
P1433
P1476
Nuclear death receptor TRAIL-R ...... creatic and other tumor cells.
@en
P2093
Alexander Bernt
Alexandra Kurz
Andreas Pickl
Anna Maria Rohde
Barbara Fleig
Charlotte Hauser
Christian Röder
Christine Böger
Christine Engler
Christoph Gelhaus
P304
P356
10.1053/J.GASTRO.2013.10.009
P407
P50
P577
2013-10-09T00:00:00Z